コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 In this open-label, phase 2 trial (TALAPRO-1), participants were recruited from 43 hospitals, cancer centres
6 From November 7, 2013, to January 16, 2019, participants were recruited from 3 University of Toronto-affi
9 China during outbreak and the after peak stages, with 2540 participants were recruited from February 6 to 16, 2020, and
10 ipants were recruited from February 6 to 16, 2020, and 2543 participants were recruited from April 25 to May 5, 2020.
15 17, we conducted a ZIKV serosurvey in Suriname in which 770 participants were recruited from 1 urban area and 2 rural vil
17 Between Jan 11, 2007, and Aug 8, 2015, 26 919 participants were recruited from 32 countries (13 447 cases [
20 To this end, 68 beginner and advanced participants were recruited from several schools practicing J
25 ertiary care academic medical centre in Miami, FL, USA, and participants were recruited from all over the USA and interna
29 A prospective cohort of 160 patients and 30 control participants were recruited from a single specialist centre.
30 ion at the Duke Eye Center, and healthy age-matched control participants were recruited from family members or friends of
31 A total of 395 frequency-matched control participants were recruited from hospital-affiliated outpatie
38 a cohort within the ongoing ARIC prospective cohort study, participants were recruited from 4 communities in the US.
40 week, phase 2, double-blind, randomised, multicentre study, participants were recruited from 45 centres (private clinics,
41 treatment as prevention was not explored in depth and that participants were recruited from academic HIV clinics in the
42 atment for chronic inflammatory bowel disease, 12.1% of the participants were recruited from a psychosomatic clinic, and
44 In this open-label, non-randomised, phase 1/2 trial, participants were recruited from four clinical sites in Kilif
45 In this open-label, single-arm, phase 3 trial, participants were recruited from 24 academic sites in the USA
46 c, three-arm, randomised, placebo-controlled phase 4 trial, participants were recruited from 20 secondary and tertiary ca
47 d, single-blind (masked independent raters) clinical trial, participants were recruited from 2 specialty academic centers
50 adaptive, randomised controlled, phase 3 superiority trial, participants were recruited from 107 cancer centres in the UK